Clinical Trials Logo

Necrosis clinical trials

View clinical trials related to Necrosis.

Filter by:

NCT ID: NCT02552069 Recruiting - Clinical trials for Rheumatoid Arthritis

Tritanium® Study in Japan

Start date: June 2015
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to evaluate early fixation and stability of the Tritanium cup. It is expected that the Tritanium® cup will be equal to or better than conventional cementless cups in early fixation/stability and meet the expectations of Japanese surgeons.

NCT ID: NCT02525783 Completed - Osteoarthritis Clinical Trials

Aequalis Pyrocarbon IDE; Replacing the Humeral Head in Hemi-Arthroplasty

PYC
Start date: December 2015
Phase:
Study type: Interventional

The purpose of this study is to demonstrate safety and effectiveness of the Aequalis Pyrocarbon Humeral Head in hemiarthroplasty at 24 months.

NCT ID: NCT02503891 Recruiting - Clinical trials for Rheumatoid Arthritis

AL-2 MP-1 (Polyimide) Acetabular Liner

Start date: September 15, 2017
Phase: N/A
Study type: Interventional

M.M.A.TECH Ltd. product is an Acetabular Liner Family produced of an advanced polyimide - MP-1™. M.M.A.TECH Ltd. produces the Liners according to EN ISO 13485:2012 approved manufacturing process and supplies them to the customer. The aim of this study is to evaluate, in the frame of PMCF, the safety and performance of using AL-X MP1 Polyimide Acetabular liners in Total Hip Replacement surgery by clinical following up of patients for a period of 2 years .

NCT ID: NCT02483650 Enrolling by invitation - Clinical trials for Carbon Monoxide Poisoning

Hyperbaric Oxygen Therapy Registry

HBOTR
Start date: January 2005
Phase:
Study type: Observational [Patient Registry]

The purpose of the Hyperbaric Oxygen Therapy Registry (HBOTR) is to provide real world patient outcome and side effect information from electronic health records submitted to a specialty specific hyperbaric registry as part of "Stage 2 of Meaningful Use," including data provided to meet PQRS requirements via the registry's QCDR mission. Goals include understanding the value of HBOT among patients treated for a variety of conditions in relation to the frequency and severity of HBOT side effects. While randomized, controlled trials can establish the efficacy of treatments like HBOT, because they routinely exclude patients with co-morbid conditions common to those patients seen in usual clinical practice, the results of RCTs are usually non-generalizable. Real world data can be used to better understand the effectiveness of HBOT among typical patients, as well as the risks associated with treatment.

NCT ID: NCT02477358 Completed - Pulpal Necrosis Clinical Trials

The Use of Platelet Rich Fibrin in Pulpal and Periodontal Regeneration in Mature Teeth

Start date: September 29, 2014
Phase: N/A
Study type: Interventional

In cases of permanent tooth avulsion, it is widely accepted that some necrosis always occurs after avulsion injury. If the pulp tissue does not revascularize or if endodontic therapy is not performed, the pulp space can become infected. Platelet rich fibrin (PRF) is a second generation platelet concentrate that allows the clinician to obtain fibrin membranes enriched with platelets and growth factors from an anticoagulant-free blood harvest. Clinical relevance of PRF and revascularization has been demonstrated in several case studies of avulsion. To date no human clinical trials have been performed evaluating the effectiveness of PRF on pulpal revascularization after reimplantation and its benefits in limiting inflammation. The following study consists of two phases: Phase 1: An in vitro model evaluating the effects of PRF in limiting inflammatory response of pdl cell cultures in the presence of an inflammatory mediators. Phase 2: An in vivo model utilizing mature teeth previously treatment planned for extraction, treating with PRF, reimplanting teeth and following for three to four months before extracting and performing histological analysis. If PRF is capable of promoting revascularization in mature teeth the potential benefits extend to limiting the need for endodontic therapy following mature tooth avulsion, potential for mature tooth transplantation in situations of congenitally missing teeth, and utilization of PRF in endodontic revascularization therapy.

NCT ID: NCT02457585 Recruiting - Clinical trials for Takayasu's Arteritis

Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis

Start date: March 2015
Phase: Phase 2
Study type: Interventional

Clinical study of anti-tumor necrosis factor therapy in patients with Takayasu arteritis. This study is single arm (anti Tumor necrosis factor therapy only) clinical trial. Enrolled patients will be 11

NCT ID: NCT02448121 Active, not recruiting - Sickle Cell Disease Clinical Trials

Autologous Bone Marrow Stem Cell Transplantation for Osteonecrosis in Sickle Cell Disease

Start date: August 2006
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of autologous bone marrow stem cells in sickle cell disease patients with osteonecrosis

NCT ID: NCT02444299 Active, not recruiting - Clinical trials for Avascular Necrosis of the Head of Humerus

Aequalis Resurfacing Head Study

Start date: April 2011
Phase:
Study type: Observational

Aequalis® Resurfacing Head implant is a range of shoulder arthroplasty device available for the treatment of various shoulder pathologies. It received CE Mark in June 2007. The aim of this study is to collect immediate medium and long term data on performance and safety of the implant, retrospectively as well as prospectively, from a consecutive series of patients to assess the patients' outcomes and functional status.

NCT ID: NCT02428582 Active, not recruiting - Arteriosclerosis Clinical Trials

Covered Stents Versus Bare-Metal Stents

Start date: May 2016
Phase: N/A
Study type: Interventional

To compare the outcome of revascularisation the gastrointestinal arteries using covered stents compared to bare-metal stents in patients with CGI.

NCT ID: NCT02424760 Active, not recruiting - Clinical trials for Avascular Necrosis of the Head of Humerus

Clinical Outcomes in Shoulder Hemi-arthroplasty Using a PyC Spherical Interpositional Implant

Start date: March 2011
Phase:
Study type: Observational

The INSPYRE implant is a new range of shoulder hemi-arthroplasty device. It consists of a Pyrocarbon spherical interpositional implant and is indicated in primary surgery to relieve severe pain or significant disability caused by degenerative pathologies. The rotator cuff must be functional. The aim of this study is to prospectively collect data from consecutive series to implement a Post Marketing Surveillance plan.